Jiang W, Cheung R, Chung C, Chan S, Choy K
Genes (Basel). 2025; 16(1).
PMID: 39858552
PMC: 11765207.
DOI: 10.3390/genes16010005.
Kurniawati E, Rahmawati N, Widyasari A
Med Sci Monit. 2025; 31():e946367.
PMID: 39815606
PMC: 11749065.
DOI: 10.12659/MSM.946367.
Cetin M, Guney G, Birge O, Arslan E, Timur B, Timur H
Medicina (Kaunas). 2024; 60(5).
PMID: 38792998
PMC: 11123034.
DOI: 10.3390/medicina60050816.
Jin X, Xu H, Hu Q, Yin Y, Qin M, Xia Z
Histochem Cell Biol. 2023; 161(2):195-205.
PMID: 37874337
DOI: 10.1007/s00418-023-02240-2.
Muro S, Akita K
Anat Sci Int. 2023; 98(3):407-425.
PMID: 36961619
PMC: 10256674.
DOI: 10.1007/s12565-023-00717-7.
Role of Fibroblasts and Myofibroblasts on the Pathogenesis and Treatment of Pelvic Organ Prolapse.
Guler Z, Roovers J
Biomolecules. 2022; 12(1).
PMID: 35053242
PMC: 8773530.
DOI: 10.3390/biom12010094.
Long-term efficacy of transvaginal high uterosacral ligament suspension for middle-compartment defect-based pelvic organ prolapse.
Wang W, Zhang Y, Shen W, Niu K, Lu Y
Ann Transl Med. 2021; 8(24):1645.
PMID: 33490157
PMC: 7812174.
DOI: 10.21037/atm-20-7296.
Pelvic Organ Prolapse: A Review of In Vitro Testing of Pelvic Support Mechanisms.
Conway C, White S, Russell R, Sentilles C, Clark-Patterson G, Miller K
Ochsner J. 2021; 20(4):410-418.
PMID: 33408579
PMC: 7755550.
DOI: 10.31486/toj.19.0089.
Oxidative Stress: A Possible Trigger for Pelvic Organ Prolapse.
Marcu R, Mischianu D, Iorga L, Diaconu C, Surcel M, Munteanu A
J Immunol Res. 2020; 2020:3791934.
PMID: 32953891
PMC: 7481916.
DOI: 10.1155/2020/3791934.
The role of transforming growth factor-ß (TGF-ß1) in postmenopausal women with pelvic organ prolapse: An immunohistochemical study.
Carlin G, Bodner K, Kimberger O, Haslinger P, Schneeberger C, Horvat R
Eur J Obstet Gynecol Reprod Biol X. 2020; 7:100111.
PMID: 32715292
PMC: 7379135.
DOI: 10.1016/j.eurox.2020.100111.
Cellular senescence: A pathogenic mechanism of pelvic organ prolapse (Review).
Huang L, Zhao Z, Wen J, Ling W, Miao Y, Wu J
Mol Med Rep. 2020; 22(3):2155-2162.
PMID: 32705234
PMC: 7411359.
DOI: 10.3892/mmr.2020.11339.
Comparison of Biaxial Biomechanical Properties of Post-menopausal Human Prolapsed and Non-prolapsed Uterosacral Ligament.
Danso E, Schuster J, Johnson I, Harville E, Buckner L, Desrosiers L
Sci Rep. 2020; 10(1):7386.
PMID: 32355180
PMC: 7193612.
DOI: 10.1038/s41598-020-64192-0.
From molecular to macro: the key role of the apical ligaments in uterovaginal support.
Kieserman-Shmokler C, Swenson C, Chen L, Desmond L, Ashton-Miller J, DeLancey J
Am J Obstet Gynecol. 2019; 222(5):427-436.
PMID: 31639371
PMC: 7166152.
DOI: 10.1016/j.ajog.2019.10.006.
The increased of MMP-9 and MMP-2 with the decreased of TIMP-1 on the uterosacral ligament after childbirth.
Rahajeng R
Pan Afr Med J. 2019; 30:283.
PMID: 30637068
PMC: 6317396.
DOI: 10.11604/pamj.2018.30.283.9905.
The role of tenascin-X in the uterosacral ligaments of postmenopausal women with pelvic organ prolapse: an immunohistochemical study.
Bodner-Adler B, Bodner K, Kimberger O, Halpern K, Schneidinger C, Haslinger P
Int Urogynecol J. 2018; 31(1):101-106.
PMID: 30535979
DOI: 10.1007/s00192-018-3820-2.
Oxidative status of cardinal ligament in pelvic organ prolapse.
Fang G, Hong L, Liu C, Yang Q, Zhang Q, Li Y
Exp Ther Med. 2018; 16(4):3293-3302.
PMID: 30250520
PMC: 6143997.
DOI: 10.3892/etm.2018.6633.
Mechanical Analysis of the Uterosacral Ligament: Swine vs. Human.
Baah-Dwomoh A, Alperin M, Cook M, De Vita R
Ann Biomed Eng. 2018; 46(12):2036-2047.
PMID: 30051246
PMC: 6249056.
DOI: 10.1007/s10439-018-2103-x.
Modelling of Soft Connective Tissues to Investigate Female Pelvic Floor Dysfunctions.
Bhattarai A, Staat M
Comput Math Methods Med. 2018; 2018:9518076.
PMID: 29568322
PMC: 5820624.
DOI: 10.1155/2018/9518076.
Tips and tricks for uterosacral ligament suspension: how to avoid ureteral injury.
Manodoro S, Frigerio M, Milani R, Spelzini F
Int Urogynecol J. 2017; 29(1):161-163.
PMID: 29038833
DOI: 10.1007/s00192-017-3497-y.
Role of transforming growth factor β‑1 in the pathogenesis of pelvic organ prolapse: A potential therapeutic target.
Liu C, Wang Y, Li B, Yang Q, Tang J, Min J
Int J Mol Med. 2017; 40(2):347-356.
PMID: 28656271
PMC: 5504969.
DOI: 10.3892/ijmm.2017.3042.